Literature DB >> 25661395

Analysis of hair cortisol level in first-episodic and recurrent female patients with depression compared to healthy controls.

Jinxue Wei1, Guizhi Sun2, Liansheng Zhao1, Xiao Yang3, Xiang Liu1, Dongtao Lin4, Tao Li1, Xiaohong Ma5.   

Abstract

BACKGROUND: Although accumulating evidence has shown increased cortisol levels in serum, saliva, or 24-h urine samples in depression, a number of studies did not find the association between cortisol levels and depression. Hair cortisol levels reflect long-term and historical information of cortisol and hair cortisol analysis has been applied in the research of psychiatric diseases. The aim of this study is to compare the hair cortisol levels between patients with depression and healthy controls.
METHODS: Hair cortisol levels of 22 first-episodic and 13 recurrent female patients with depression and 30 healthy controls were measured and compared using the electrochemiluminescence immunoassay. The relationship between hair cortisol levels and Hamilton depression scale (HAMD) or Hamilton anxiety scale (HAMA) scores were also examined.
RESULTS: Before disease episode, no significant differences were observed among healthy controls, first-episodic patients and recurrent patients. In disease episode, the hair cortisol level in first-episodic patients was significantly higher than that in healthy controls or recurrent patients, while no significant difference was observed between recurrent patients and healthy controls. No significant correlation was found between HAMD or HAMA scores and hair cortisol levels in patients. LIMITATIONS: First, long-term effects of antidepressants on the results cannot be excluded without detailed medication information of the recurrent patients. Second, sample sizes might be relatively small.
CONCLUSIONS: Our results indicate that hair cortisol levels increased in disease episode in first-episodic, but not recurrent patients with depression, which may suggest that episodes of disease have influence on cortisol levels.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; First-episode; Hair cortisol; Recurrence

Mesh:

Substances:

Year:  2015        PMID: 25661395     DOI: 10.1016/j.jad.2015.01.023

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  22 in total

1.  Acute stress response to a cognitive task in patients with major depressive disorder: potential metabolic and proinflammatory biomarkers.

Authors:  Tatiana Druzhkova; Ksenia Pochigaeva; Aleksander Yakovlev; Evdokia Kazimirova; Maria Grishkina; Aleksey Chepelev; Alla Guekht; Natalia Gulyaeva
Journal:  Metab Brain Dis       Date:  2018-12-18       Impact factor: 3.584

2.  Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.

Authors:  Ksenia Pochigaeva; Tatiana Druzhkova; Alexander Yakovlev; Mikhail Onufriev; Maria Grishkina; Aleksey Chepelev; Alla Guekht; Natalia Gulyaeva
Journal:  Metab Brain Dis       Date:  2017-01-07       Impact factor: 3.584

3.  Hair cortisol in pregnancy interacts with maternal depressive symptoms to predict maternal disrupted interaction with her infant at 4 months.

Authors:  Jennifer E Khoury; Michelle Bosquet Enlow; Mariya C Patwa; Karlen Lyons-Ruth
Journal:  Dev Psychobiol       Date:  2020-02-09       Impact factor: 3.038

4.  Examining reactivity patterns in burnout and other indicators of chronic stress.

Authors:  Magdalena K Wekenborg; Bernadette von Dawans; LaBarron K Hill; Julian F Thayer; Marlene Penz; Clemens Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2019-04-04       Impact factor: 4.905

5.  Chronic stress in the mother-infant dyad: Maternal hair cortisol, infant salivary cortisol and interactional synchrony.

Authors:  Amanda R Tarullo; Ashley Moore St John; Jerrold S Meyer
Journal:  Infant Behav Dev       Date:  2017-04-06

6.  Hair-based biomarkers in women with major depressive disorder: Glucocorticoids, endocannabinoids, N-acylethanolamines, and testosterone.

Authors:  Alexander Behnke; Anja M Gumpp; Aniko Krumbholz; Alexandra M Bach; Gustav Schelling; Iris-Tatjana Kolassa; Roberto Rojas
Journal:  Compr Psychoneuroendocrinol       Date:  2021-06-21

7.  Effects of Modified Electroconvulsive Therapy on Serum Cortisol, Nesfatin-1, and Pro-inflammatory Cytokine Levels in Elderly Patients With Treatment-Resistant Depression.

Authors:  Biao Dai; Xiaoping Wu; Fanfan Yan; Yang Chen; Yayun Xu; Qingrong Xia; Xulai Zhang; Xuefeng Xie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

8.  FKBP5 DNA methylation does not mediate the association between childhood maltreatment and depression symptom severity in the Detroit Neighborhood Health Study.

Authors:  Angela C Bustamante; Allison E Aiello; Guia Guffanti; Sandro Galea; Derek E Wildman; Monica Uddin
Journal:  J Psychiatr Res       Date:  2017-09-18       Impact factor: 4.791

Review 9.  Hypothalamic-Pituitary-End-Organ Axes: Hormone Function in Female Patients with Major Depressive Disorder.

Authors:  Yuncheng Zhu; Xiaohui Wu; Rubai Zhou; Oliver Sie; Zhiang Niu; Fang Wang; Yiru Fang
Journal:  Neurosci Bull       Date:  2021-04-28       Impact factor: 5.271

10.  The relationship between labor pain management, cortisol level and risk of postpartum depression development: a prospective nonrandomized observational monocentric trial.

Authors:  Oksana V Riazanova; Yurii S Alexandrovich; Alexander M Ioscovich
Journal:  Rom J Anaesth Intensive Care       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.